HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luca Gambini Selected Research

Antineoplastic Agents (Antineoplastics)

1/2017hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luca Gambini Research Topics

Disease

9Neoplasms (Cancer)
11/2022 - 01/2016
4Neoplasm Metastasis (Metastasis)
10/2020 - 01/2018
3Breast Neoplasms (Breast Cancer)
06/2021 - 01/2016
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2022 - 07/2018
2Prostatic Neoplasms (Prostate Cancer)
10/2020 - 12/2016
2Infections
11/2017 - 01/2015
2Malaria
01/2016 - 01/2015
1Melanoma (Melanoma, Malignant)
11/2021
1Confusion (Bewilderment)
01/2020
1Multiple Myeloma
07/2018
1Leukemia
07/2018
1Circulating Neoplastic Cells
01/2018
1Shock
11/2017
1Septic Shock (Toxic Shock Syndrome)
11/2017
1Sepsis (Septicemia)
11/2017
1Hyperthermia
12/2016
1Parkinson Disease (Parkinson's Disease)
06/2014

Drug/Important Bio-Agent (IBA)

4Peptides (Polypeptides)IBA
01/2018 - 01/2016
3Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2017
3EphA2 ReceptorIBA
10/2020 - 01/2018
2LigandsIBA
11/2022 - 10/2020
2Paclitaxel (Taxol)FDA LinkGeneric
11/2022 - 01/2018
2GoldIBA
12/2016 - 01/2016
2Peptide Hydrolases (Proteases)FDA Link
01/2016 - 01/2015
2plasmepsin (plasmepsin I)IBA
01/2016 - 01/2015
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2022
1Lysine (L-Lysine)FDA Link
11/2021
1Indicators and Reagents (Reagents)IBA
06/2021
1StreptavidinIBA
06/2021
1enzalutamideIBA
10/2020
1Serine Proteases (Serine Protease)IBA
01/2020
1LCL161IBA
07/2018
1ResistinIBA
11/2017
1LipopolysaccharidesIBA
11/2017
1Antineoplastic Agents (Antineoplastics)IBA
01/2017
1Neuropeptide Y Receptors (Neuropeptide Y Receptor)IBA
12/2016
1Neuropeptide YIBA
12/2016
1NanoconjugatesIBA
01/2016
1Peptide LibraryIBA
01/2016
1EnzymesIBA
01/2015
1iotrochotazine AIBA
06/2014

Therapy/Procedure

5Therapeutics
11/2022 - 12/2016
4Drug Therapy (Chemotherapy)
11/2022 - 01/2017
1Immunomodulation
11/2017
1Photothermal Therapy
12/2016
1Lasers (Laser)
12/2016
1Precision Medicine
12/2016